Source:http://linkedlifedata.com/resource/pubmed/id/18183075
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2008-1-9
|
pubmed:abstractText |
Hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis induces hyperglycemia and serotonin (5-HT)2A receptor supersensitivity. In the present study, to investigate the effect of hyperglycemia on the function of 5-HT2A receptors, we compared the 5-HT2A receptor-mediated wet-dog shake responses in rats treated with adrenocorticotropic hormone (ACTH), dexamethasone and streptozotocin. ACTH (100 ug/rat per day, s.c.), dexamethasone (1 mg/kg per day, s.c.) and streptozotocin (60 mg/kg, i.p.) produced significant hyperglycemia at 14 days after the start of these treatments, and the hyperglycemia was most pronounced in the streptozotocin-treated rats. The wet-dog shake responses induced by (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI), a 5-HT2A receptor agonist, were significantly enhanced at 14 days after repeated treatment with ACTH and dexamethasone. However, streptozotocin-induced diabetes had no effect on the wet-dog shake responses. The results of the present study suggest that hyperglycemia is not strongly associated with the enhanced susceptibility of 5-HT2A receptors under the condition of hyperactivity of the HPA axis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adrenocorticotropic Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/Dexamethasone,
http://linkedlifedata.com/resource/pubmed/chemical/Glucocorticoids,
http://linkedlifedata.com/resource/pubmed/chemical/Hormones,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Serotonin, 5-HT2A,
http://linkedlifedata.com/resource/pubmed/chemical/Streptozocin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0386-300X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
61
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
311-7
|
pubmed:meshHeading |
pubmed-meshheading:18183075-Adrenocorticotropic Hormone,
pubmed-meshheading:18183075-Animals,
pubmed-meshheading:18183075-Behavior, Animal,
pubmed-meshheading:18183075-Dexamethasone,
pubmed-meshheading:18183075-Diabetes Mellitus, Experimental,
pubmed-meshheading:18183075-Glucocorticoids,
pubmed-meshheading:18183075-Hormones,
pubmed-meshheading:18183075-Hyperglycemia,
pubmed-meshheading:18183075-Hypothalamo-Hypophyseal System,
pubmed-meshheading:18183075-Male,
pubmed-meshheading:18183075-Pituitary-Adrenal System,
pubmed-meshheading:18183075-Rats,
pubmed-meshheading:18183075-Rats, Wistar,
pubmed-meshheading:18183075-Receptor, Serotonin, 5-HT2A,
pubmed-meshheading:18183075-Stereotyped Behavior,
pubmed-meshheading:18183075-Streptozocin
|
pubmed:year |
2007
|
pubmed:articleTitle |
The Influence of hyperactivity of the hypothalamic-pituitary-adrenal axis and hyperglycemia on the 5-HT2A receptor-mediated wet-dog shake responses in rats.
|
pubmed:affiliation |
Department of Clinical Pharmacology and Pharmacy, Ehime University Graduate School of Medicine, Toon, Ehime 791-0295, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|